A 16-year-old male with mucinous adenocarcinoma (pT4N0M0) showing loss of MSH2/MSH6 expression received 12 cycles of adjuvant FOLFOX chemotherapy and remains disease-free more than 5 years after completion of therapy. (Am J Case Rep)
16-year-old with MSI-H CRC remains disease-free 5+ years after adjuvant FOLFOX
The CRC Digest